Cranbrook Wealth Management, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cranbrook Wealth Management, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$20,313
-1.5%
1,3130.0%0.01%0.0%
Q2 2023$20,628
-4.7%
1,3130.0%0.01%0.0%
Q1 2023$21,639
+5.6%
1,3130.0%0.01%0.0%
Q4 2022$20,483
+20.5%
1,3130.0%0.01%
+50.0%
Q3 2022$17,000
-5.6%
1,3130.0%0.00%
-20.0%
Q2 2022$18,000
-5.3%
1,3130.0%0.01%
+25.0%
Q1 2022$19,000
+5.6%
1,3130.0%0.00%0.0%
Q4 2021$18,000
-18.2%
1,3130.0%0.00%
-20.0%
Q3 2021$22,0000.0%1,3130.0%0.01%0.0%
Q2 2021$22,000
-8.3%
1,3130.0%0.01%
-16.7%
Q1 2021$24,0000.0%1,3130.0%0.01%0.0%
Q4 2020$24,000
+4.3%
1,3130.0%0.01%
-14.3%
Q3 2020$23,000
-4.2%
1,3130.0%0.01%0.0%
Q2 2020$24,000
+20.0%
1,3130.0%0.01%0.0%
Q1 2020$20,000
-23.1%
1,3130.0%0.01%0.0%
Q4 2019$26,000
+13.0%
1,3130.0%0.01%0.0%
Q3 2019$23,0000.0%1,3130.0%0.01%0.0%
Q2 2019$23,000
-14.8%
1,3130.0%0.01%
-12.5%
Q1 2019$27,0001,3130.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders